Description
Cell to transfect:
Designations: A549
Cell Synonyms: : CCL-185, NCI60, NCI-60, human lung carcinoma cell
Depositors: M Lieber
Growth Properties: adherent
Organism: Homo sapiens
Morphology: epithelial
Organ: lung
Disease: carcinoma
Isolation: Isolation date: 1972
Applications: transfection host
Isoenzymes: G6PD, B
Age: 58 years
Gender: male
Ethnicity: Caucasian
This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old Caucasian male. Further studies by M. Lieber, et al. revealed that A549 cells could synthesize lecithin with a high percentage of desaturated fatty acids utilizing the cytidine diphosphocholine pathway. The cells are positive for keratin by immunoperoxidase staining.
A549 is one of the cell lines of the NCI-60 panel which represents different cancer types and has been widely utilized for drug screening and molecular target identification.
Features of The Transfection Reagent:
- Broad spectrum for the transfection of large plasmid, mRNA, siRNA, and/or other type of nucleic acids, which is best for co-transfection of different type and/or size of nucleic acids.
- Unique formulation-maximize transfection performance in A549 cells.
- Lowest Cellular Toxicity-maintain cell density and reduce experimental biases
- 0.5 ml is able to transfect about 1000 wells of 24-well plate
- Deliver single or multiple plasmids
- Synthesized from 100% animal origin-free components, making it easy to validate the absence of zoonotic diseases, such as BSE or viruses, in research experiments or cells lines
- Compatible with serum
- Compatible with transfection in any plate formats
- Economical: High efficiency means less amount of nucleic acid & reagent is needed
- Developed and manufactured by EZ Biosystems
Data®
FIG. 1. High throughput test of transfection efficiency (determined as RLU/mg) on A549 cells after transfection of luciferase reporter gene by using our 172 proprietary transfection formulas and several most popular commercial transfection reagents. The yellow box showed the results of 4 commercial transfection reagents. The red lines marked our candidate formulas with the highest transfection efficiency for A549 cells. This test result was confirmed with repeat experiments. The one that showed the optimal balance of potent & low cytotoxicity among those candidate formulas after flow cytometry analysis on the percentage of 7AAD positive cells was later named as this A549 Cell Avalanche Transfection Reagent.
For Other Cells
A549 Cell Avalanche® Transfection Reagent (human lung carcinoma cell) can also be used on the following cells with high transfection efficiencies.
NCI-H292 Cell
NCI-H460 Cell
NCI-H1299 Cell
NCI-H23 Cell
NCI-H1975 Cell
NCI-H441 Cell
Calu-3 Cell
NCI-H358 Cell
293 Cell
Recommended protocols for these cells will be provided with the reagent. The protocols usually provide satisfactory transfection efficiency with invisible cytotoxicity. However, optimization may be needed for certain type of cells. Optimizations may include: the amount of DNA and this transfection reagent; cell density; transfection reagent/DNA ratio, or incubation time for the mixture of transfection reagent/DNA etc. For best transfection result, we recommend using the respective cell type/cell line specific Avalanche transfection reagents. Those reagents have been optimized on both recipes and protocols, and have been proved to have the best transfection results for the respective cell lines or primary cells. You can easily find the respective Avalanche transfection reagents specific for your cells by using the filters of our product list.
Additional Information
| Weight |
0.5 lbs |
| Adherence Phenotype |
Adherent |
| Cell Type |
Epithelial Cell |
| Disease |
Cancer |
| Names starting from |
A |
| Primary/Cell Line |
Cell Line |
| Product Sizes |
0.5 ml, 1.5 ml |
| Species |
Human |
| Tissue Sources |
Lung |
| Subcategories |
Cell Type/Cell Line Specific |
Documents
Protocols
EZT-A549-1 Protocol.
MSDS
EZT-A549-1 MSDS
Citations or Feedback
- Siegers, J. Y., Ferreri, L., Eggink, D., Veldhuis Kroeze, E. J. B., Te Velthuis, A. J. W., van de Bildt, M., . . . van Riel, D. (2023). Evolution of highly pathogenic H5N1 influenza A virus in the central nervous system of ferrets. PLoS Pathog, 19(3), e1011214. doi:10.1371/journal.ppat.1011214
Description
Cell to transfect:
Designations: A549
Cell Synonyms: : CCL-185, NCI60, NCI-60, human lung carcinoma cell
Depositors: M Lieber
Growth Properties: adherent
Organism: Homo sapiens
Morphology: epithelial
Organ: lung
Disease: carcinoma
Isolation: Isolation date: 1972
Applications: transfection host
Isoenzymes: G6PD, B
Age: 58 years
Gender: male
Ethnicity: Caucasian
This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old Caucasian male. Further studies by M. Lieber, et al. revealed that A549 cells could synthesize lecithin with a high percentage of desaturated fatty acids utilizing the cytidine diphosphocholine pathway. The cells are positive for keratin by immunoperoxidase staining.
A549 is one of the cell lines of the NCI-60 panel which represents different cancer types and has been widely utilized for drug screening and molecular target identification.
Features of The Transfection Reagent:
- Broad spectrum for the transfection of large plasmid, mRNA, siRNA, and/or other type of nucleic acids, which is best for co-transfection of different type and/or size of nucleic acids.
- Unique formulation-maximize transfection performance in A549 cells.
- Lowest Cellular Toxicity-maintain cell density and reduce experimental biases
- 0.5 ml is able to transfect about 1000 wells of 24-well plate
- Deliver single or multiple plasmids
- Synthesized from 100% animal origin-free components, making it easy to validate the absence of zoonotic diseases, such as BSE or viruses, in research experiments or cells lines
- Compatible with serum
- Compatible with transfection in any plate formats
- Economical: High efficiency means less amount of nucleic acid & reagent is needed
- Developed and manufactured by EZ Biosystems
Data®
FIG. 1. High throughput test of transfection efficiency (determined as RLU/mg) on A549 cells after transfection of luciferase reporter gene by using our 172 proprietary transfection formulas and several most popular commercial transfection reagents. The yellow box showed the results of 4 commercial transfection reagents. The red lines marked our candidate formulas with the highest transfection efficiency for A549 cells. This test result was confirmed with repeat experiments. The one that showed the optimal balance of potent & low cytotoxicity among those candidate formulas after flow cytometry analysis on the percentage of 7AAD positive cells was later named as this A549 Cell Avalanche Transfection Reagent.
For Other Cells
A549 Cell Avalanche® Transfection Reagent (human lung carcinoma cell) can also be used on the following cells with high transfection efficiencies.
NCI-H292 Cell
NCI-H460 Cell
NCI-H1299 Cell
NCI-H23 Cell
NCI-H1975 Cell
NCI-H441 Cell
Calu-3 Cell
NCI-H358 Cell
293 Cell
Recommended protocols for these cells will be provided with the reagent. The protocols usually provide satisfactory transfection efficiency with invisible cytotoxicity. However, optimization may be needed for certain type of cells. Optimizations may include: the amount of DNA and this transfection reagent; cell density; transfection reagent/DNA ratio, or incubation time for the mixture of transfection reagent/DNA etc. For best transfection result, we recommend using the respective cell type/cell line specific Avalanche transfection reagents. Those reagents have been optimized on both recipes and protocols, and have been proved to have the best transfection results for the respective cell lines or primary cells. You can easily find the respective Avalanche transfection reagents specific for your cells by using the filters of our product list.
Additional Information
| Weight |
0.5 lbs |
| Adherence Phenotype |
Adherent |
| Cell Type |
Epithelial Cell |
| Disease |
Cancer |
| Names starting from |
A |
| Primary/Cell Line |
Cell Line |
| Product Sizes |
0.5 ml, 1.5 ml |
| Species |
Human |
| Tissue Sources |
Lung |
| Subcategories |
Cell Type/Cell Line Specific |
Documents
Protocols
EZT-A549-1 Protocol.
MSDS
EZT-A549-1 MSDS
Citations or Feedback
- Siegers, J. Y., Ferreri, L., Eggink, D., Veldhuis Kroeze, E. J. B., Te Velthuis, A. J. W., van de Bildt, M., . . . van Riel, D. (2023). Evolution of highly pathogenic H5N1 influenza A virus in the central nervous system of ferrets. PLoS Pathog, 19(3), e1011214. doi:10.1371/journal.ppat.1011214
